Stress Management for Cancer Patients: How Well Does it Work? (C2H-D)
NCT ID: NCT02070250
Last Updated: 2021-09-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
158 participants
INTERVENTIONAL
2013-11-30
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stress and Immunity Breast Cancer Project
NCT03578627
Implementing Systematic Distress Screening in Breast Cancer
NCT02941614
Stress Management Intervention for Mothers of Children With Cancer
NCT02022449
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
NCT01764789
Psychosocial Support in Treating Women With Recurrent Breast Cancer or Stage I, Stage II, or Stage IV Breast Cancer
NCT00416780
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
From Cancer to Health (C2H-D)
Individuals participating in the From Cancer to Health (C2H-D) Stress Management Psychological Intervention
From Cancer to Health (C2H-D)
From Cancer to Health gives people with cancer the information and tools they need to manage their stress to improve their health throughout the cancer journey. Each institution involved in this study will implement the core techniques of the C2H-D Intervention but may alter the format somewhat to meet their patient population needs (e.g., shorten hourly 18 week intervention into 2-hour 9 week intervention).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
From Cancer to Health (C2H-D)
From Cancer to Health gives people with cancer the information and tools they need to manage their stress to improve their health throughout the cancer journey. Each institution involved in this study will implement the core techniques of the C2H-D Intervention but may alter the format somewhat to meet their patient population needs (e.g., shorten hourly 18 week intervention into 2-hour 9 week intervention).
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to speak/read English
Exclusion Criteria
* Dementia
* Mental retardation
* non-English speaking
* Significant sensory deficit
* Severe mental illness (e.g., schizophrenia, psychotic disorder)
21 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Ohio State University Comprehensive Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barbara Andersen
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barbara L Andersen, PhD
Role: PRINCIPAL_INVESTIGATOR
Ohio State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cancer Center of East Alabama Medical Center
Auburn, Alabama, United States
UC Davis Comprehensive Cancer Center
Sacramento, California, United States
Providence Saint John's Health Center
Santa Monica, California, United States
Tahoe Forest Cancer Center
Truckee, California, United States
Wellness House
Hinsdale, Illinois, United States
Cancer Wellness Center
Northbrook, Illinois, United States
IU Health Ball Memorial Hospital
Muncie, Indiana, United States
Genesis Health Center
Davenport, Iowa, United States
Unity Point Health/Gilda's Club Quad Cities
Davenport, Iowa, United States
University of Kentucky Markey Cancer Center
Lexington, Kentucky, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
OSU Stephanie Spielman Comprehensive Breast Center
Columbus, Ohio, United States
Geisinger Medical Center
Danville, Pennsylvania, United States
Seton UT Southwestern
Austin, Texas, United States
Baylor Regional Medical Center at Plano, Texas
Plano, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ashmore JA, Ditterich KW, Conley CC, Wright MR, Howland PS, Huggins KL, Cooreman J, Andrews PS, Nicholas DR, Roberts L, Hewitt L, Scales JN, Delap JK, Gray CA, Tyler LA, Collins C, Whiting CM, Brothers BM, Ryba MM, Andersen BL. Evaluating the effectiveness and implementation of evidence-based treatment: A multisite hybrid design. Am Psychol. 2019 May-Jun;74(4):459-473. doi: 10.1037/amp0000309. Epub 2018 Jul 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OSU-13127
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.